[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cbdmd Inc (YCBD)

Cbdmd Inc (YCBD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
cbdMD Sets a New Safety Standard for Broad Spectrum CBD With Self-Affirmed GRAS Determination

Years of peer-reviewed safety research position cbdMD's broad spectrum CBD for a new era of evidence-based, clinically supported wellness.

YCBD : 0.7500 (+1.64%)
Oasis Launches Hemp-Derived Mixer

A quadruple-filtered, zero-proof spirit with a resealable, child-resistant cap; ready to enjoy on its own or built into a mocktail

YCBD : 0.7500 (+1.64%)
cbdMD Welcomes White House Call for Fair Treatment of Hemp-Derived Products

As federal reclassification efforts advance and major U.S. exchanges open to compliant operators, cbdMD points to its position as an established, NYSE American–listed company in a maturing cannabinoid...

YCBD : 0.7500 (+1.64%)
cbdMD Appoints Wade Brown Chief Marketing Officer

Veteran consumer-wellness growth operator to lead multi-brand expansion across DTC, Amazon, retail, and new categories

YCBD : 0.7500 (+1.64%)
cbdMD Reports 19% Year-over-Year and 12% Sequential Revenue Growth; Bluebird Acquisition Integration and Medicare BEI Pathway Position Company for Continued Momentum

CHARLOTTE, N.C.  , May 14, 2026 /PRNewswire/ -- cbdMD, Inc. (NYSE American: YCBD), one of the nation's leading and most trusted CBD companies and operator of the cbdMD, Bluebird Botanicals, and...

YCBD : 0.7500 (+1.64%)
cbdMD, Inc. to Host Conference Call to Discuss March 31, 2026, Second Quarter Results

CHARLOTTE, N.C. , May 12, 2026 /PRNewswire/ -- cbdMD, Inc. ( NYSE American: YCBD) , one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will...

YCBD : 0.7500 (+1.64%)
Hawkeye Systems Announces New Board Members With Deep Capital Markets, Governance, Legal, and Merchant Banking Experience

The Board Expansion Is Led By Wall Street Veteran Marty Sumichrast as Chairman, In Addition to Sim Farar, Brad Fleisher, Ralph Olson, and Corby Marshall

BGH : 14.16 (-0.42%)
YCBD : 0.7500 (+1.64%)
GCAP : 6.04 (-0.82%)
HWKE : 0.1600 (-20.00%)
cbdMD Launches Clinical Healthcare Channel to Support First Federal Pathway for Hemp-Derived CBD in Medicare

Company brings one of the only combined clinical and toxicological safety dataset in the hemp-derived CBD category into a new provider channel as CMS activates cannabinoid access within value-based care...

YCBD : 0.7500 (+1.64%)
cbdMD Reports Sequential Revenue Growth, Improved Liquidity, and Strong Start to Fiscal 2026

CHARLOTTE, N.C. , Feb. 17, 2026 /PRNewswire/ -- cbdMD, Inc. (NYSE American: YCBD), one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD...

YCBD : 0.7500 (+1.64%)
cbdMD, Inc. to Host Conference Call to Discuss December 31, 2025 First Quarter Results

CHARLOTTE, N.C. , Feb. 12, 2026 /PRNewswire/ -- cbdMD, Inc. ( NYSE American: YCBD) , one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will...

YCBD : 0.7500 (+1.64%)

Barchart Exclusives

Nike’s Dividend Yield Is Near Record Highs, But That’s Not a Good Enough Reason to Buy NKE Stock
Nike's dividend yield is nearly 3.8%, which is near the record highs we saw last month. That, however, does not make the stock a buy. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.